Pennsylvania 2025-2026 Regular Session Status: In Committee Bipartisan · 29 D · 3 R cosponsors

HB 2226 — An Act amending Title 40 (Insurance) of the Pennsylvania Consolidated Statutes, providing for prescription drug cost credits in health insurance; and imposing penalties.

Last action — Re-committed to Rules

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House. Introduced February 19, 2026. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Likely to advance 62% · high confidence
  • In Committee

    Current position in the legislative process.

  • 32 sponsors

    1 primary, 31 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (29 D · 3 R) — cross-party backing.

  • Cleared a recorded vote

    Passed 2 recorded votes so far.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

In plain language

This bill addresses prescription drug cost credits in health insurance in Pennsylvania.

The bill amends Pennsylvania's insurance laws to include provisions for prescription drug cost credits. It also establishes penalties related to these provisions.

What this means for you
  • Families: Families may benefit from lower prescription drug expenses through adjustments in their health insurance plans.
  • Consumers: This could result in reduced costs for prescription medications for consumers with health insurance coverage.
  • Healthcare: This means healthcare providers may need to adjust their practices to comply with new insurance requirements.

Bill Text

What changed in the latest version

436 added · 203 removed

Plain-language change summary

The revised version of Bill HB 2226 includes additional sponsors who support the bill, enhancing its backing. It also clarifies definitions related to deceptive practices in advertising and sales to protect consumers better. These changes matter because they help ensure that businesses are held accountable for their representations, reducing the likelihood of misleading or false claims, which ultimately benefits consumers by providing clearer standards.

→
Previous
Latest
PRINTER'S NO.
PRIOR PRINTER'S NO.
2917 THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE BILL Session of No.
2917 PRINTER'S NO.
2226 2026 INTRODUCED BY KINKEAD, KUZMA, KHAN, HANBIDGE, PARKER, McNEILL, HOHENSTEIN, SCOTT, DOUGHERTY, FLEMING, GAYDOS, SHUSTERMAN, PROKOPIAK, HOWARD, SANCHEZ, KAZEEM AND SALISBURY, FEBRUARY 18, 2026 REFERRED TO COMMITTEE ON INSURANCE, FEBRUARY 19, 2026 AN ACT Amending the act of December 17, 1968 (P.L.1224, No.387), entitled "An act prohibiting unfair methods of competition and unfair or deceptive acts or practices in the conduct of any trade or commerce, giving the Attorney General and District Attorneys certain powers and duties and providing penalties," further providing for definitions and for concurrent jurisdiction.es and exclusions;
3706 THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE BILL Session of No.
and providing for The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:
2226 2026 INTRODUCED BY KINKEAD, KUZMA, KHAN, HANBIDGE, PARKER, McNEILL, HOHENSTEIN, SCOTT, DOUGHERTY, FLEMING, GAYDOS, SHUSTERMAN, PROKOPIAK, HOWARD, SANCHEZ, KAZEEM, SALISBURY, M.
MACKENZIE, FIEDLER, PIELLI, BRENNAN, MADDEN, MATZIE, MARKOSEK, GOUGHNOUR, BRIGGS AND FRIEL, FEBRUARY 18, 2026 AS REPORTED FROM COMMITTEE ON INSURANCE, HOUSE OF REPRESENTATIVES, AS AMENDED, JUNE 24, 2026 AN ACT Amending the act of December 17, 1968 (P.L.1224, No.387), <-- entitled "An act prohibiting unfair methods of competition and unfair or deceptive acts or practices in the conduct of any trade or commerce, giving the Attorney General and penalties," further providing for definitions and foriding unlawful acts or practices and exclusions;
and providing for concurrent jurisdiction.
The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:
(xii) Promising or offering prior to time of sale to pay, credit or allow to any buyer, any compensation or reward for the 20260HB2226PN2917 - 2 - procurement of a contract for purchase of goods or services with another or others, or for the referral of the name or names of another or others for the purpose of attempting to procure or procuring such a contract of purchase with such other person or persons when such payment, credit, compensation or reward is contingent upon the occurrence of an event subsequent to the time of the signing of a contract to purchase;
(xii) Promising or offering prior to time of sale to pay, 20260HB2226PN3706 - 2 - credit or allow to any buyer, any compensation or reward for the procurement of a contract for purchase of goods or services with another or others, or for the referral of the name or names of another or others for the purpose of attempting to procure or procuring such a contract of purchase with such other person or persons when such payment, credit, compensation or reward is contingent upon the occurrence of an event subsequent to the time of the signing of a contract to purchase;
The term "Pyramid Promotional Scheme" means any plan or operation by which a person gives consideration for the opportunity to receive compensation that is derived primarily from the introduction of other persons into the plan or operation rather than from the sale and consumption of goods, services or intangible property by a participant or other persons introduced into the plan or operation.
The term "Pyramid Promotional Scheme" means any plan or operation by which a person gives consideration for the opportunity to receive compensation that is derived primarily from the introduction of other persons into the plan or operation rather than from the sale and consumption of goods, services or intangible property by a participant or 20260HB2226PN3706 - 3 - other persons introduced into the plan or operation.
The term 20260HB2226PN2917 - 3 - includes any plan or operation under which the number of people who may participate is limited either expressly or by the application of conditions affecting the eligibility of a person to receive compensation under the plan or operation, and includes any plan or operation under which a person, on giving any consideration, obtains any goods, services or intangible property in addition to the right to receive compensation.
The term includes any plan or operation under which the number of people who may participate is limited either expressly or by the application of conditions affecting the eligibility of a person to receive compensation under the plan or operation, and includes any plan or operation under which a person, on giving any consideration, obtains any goods, services or intangible property in addition to the right to receive compensation.
(C) the nature of the goods or services;
20260HB2226PN3706 - 4 - (C) the nature of the goods or services;
and 20260HB2226PN2917 - 4 - (D) that no purchase or payment is necessary to be able to win a prize or participate in a prize promotion if a prize promotion is offered.
and (D) that no purchase or payment is necessary to be able to win a prize or participate in a prize promotion if a prize promotion is offered.
(A) that any rustproofing of the new motor vehicle offered by the motor vehicle dealer is optional;
(A) that any rustproofing of the new motor vehicle offered 20260HB2226PN3706 - 5 - by the motor vehicle dealer is optional;
20260HB2226PN2917 - 5 - (B) that the new motor vehicle has been rustproofed by the manufacturer and the nature and extent, if any, of the manufacturer's warranty which is applicable to that rustproofing;
(B) that the new motor vehicle has been rustproofed by the manufacturer and the nature and extent, if any, of the manufacturer's warranty which is applicable to that rustproofing;
Exclusions.--(a) Unfair methods of competition and unfair or deceptive acts or practices in the conduct of any trade or commerce as defined by subclauses (i) through [(xxi)] (xxii) of clause (4) of section 2 of this act and regulations promulgated under section 3.1 of 20260HB2226PN2917 - 6 - this act are hereby declared unlawful.
Exclusions.--(a) Unfair methods of competition and unfair or deceptive acts or practices in the conduct of any trade or commerce as defined by subclauses (i) through [(xxi)] (xxii) of clause (4) of section 2 20260HB2226PN3706 - 6 - of this act and regulations promulgated under section 3.1 of this act are hereby declared unlawful.
§ 223), this act shall apply only if the health savings account is also a health savings account-qualified high deductible health plan with respect to the deductible of the plan after the enrollee has satisfied the minimum deductible under section 223 of the 20260HB2226PN2917 - 7 - Internal Revenue Code of 1986, except with respect to items or services that are preventive care under section 223(c)(2)(C) of the Internal Revenue Code of 1986, in which case the requirements of this section shall apply regardless of whether the minimum deductible under section 223 of the Internal Revenue Code of 1986 has been satisfied.
§ 223), this act shall apply only if the health savings account is also a health savings account-qualified high deductible health plan with respect to the deductible of the plan after the enrollee has 20260HB2226PN3706 - 7 - satisfied the minimum deductible under section 223 of the Internal Revenue Code of 1986, except with respect to items or services that are preventive care under section 223(c)(2)(C) of the Internal Revenue Code of 1986, in which case the requirements of this section shall apply regardless of whether the minimum deductible under section 223 of the Internal Revenue Code of 1986 has been satisfied.
20260HB2226PN2917 - 8 -
AMENDING TITLE 40 (INSURANCE) OF THE PENNSYLVANIA CONSOLIDATED STATUTES, PROVIDING FOR PRESCRIPTION DRUG COST CREDITS IN <-- HEALTH INSURANCE;
AND IMPOSING PENALTIES.
THE GENERAL ASSEMBLY OF THE COMMONWEALTH OF PENNSYLVANIA HEREBY ENACTS AS FOLLOWS:
SECTION 1.
TITLE 40 OF THE PENNSYLVANIA CONSOLIDATED STATUTES IS AMENDED BY ADDING A CHAPTER TO READ:
CHAPTER 52 FAIR CO-PAY ASSISTANCE CREDITS SUBCHAPTER A.
PRELIMINARY PROVISIONS B.
FAIR CO-PAY ASSISTANCE CREDITS C.
MISCELLANEOUS PROVISIONS SUBCHAPTER A PRELIMINARY PROVISIONS SEC.
5201.
SCOPE OF CHAPTER.
5202.
DEFINITIONS.
§ 5201.
SCOPE OF CHAPTER.
THIS CHAPTER RELATES TO THE CREDITING OF CO-PAY ASSISTANCE PROVIDED FOR PRESCRIPTION DRUGS TOWARD HEALTH BENEFIT PLAN COST- SHARING.
THIS CHAPTER DOES NOT APPLY TO A SELF-INSURED HEALTH BENEFIT PLAN SUBJECT TO 29 U.S.C.
CH.
18 (RELATING TO EMPLOYEE 20260HB2226PN3706 - 8 - RETIREMENT INCOME SECURITY PROGRAM) OR EXEMPTED FROM 29 U.S.C.
CH.
18.
§ 5202.
DEFINITIONS.
THE FOLLOWING WORDS AND PHRASES WHEN USED IN THIS CHAPTER SHALL HAVE THE MEANINGS GIVEN TO THEM IN THIS SECTION UNLESS THE CONTEXT CLEARLY INDICATES OTHERWISE:
Show all 140 changed rows (100 more)
Previous
Latest
"COMMISSIONER." THE INSURANCE COMMISSIONER OF THE COMMONWEALTH.
"COST-SHARING." MEANS AS FOLLOWS:
(1) THE SHARE OF THE HEALTH CARE COSTS COVERED BY A HEALTH BENEFIT PLAN THAT A COVERED PERSON PAYS OUT-OF-POCKET.
(2) THE TERM INCLUDES DEDUCTIBLES, COINSURANCE, COPAYMENTS AND SIMILAR CHARGES.
(3) THE TERM DOES NOT INCLUDE PREMIUMS, BALANCE BILLED AMOUNTS FROM AN OUT-OF-NETWORK HEALTH CARE PROVIDER OR THE COST OF NONCOVERED SERVICES EXCEPT AS SPECIFIED IN THIS CHAPTER.
"COVERED PERSON." A POLICYHOLDER, SUBSCRIBER OR OTHER INDIVIDUAL WHO IS ENTITLED TO RECEIVE HEALTH CARE SERVICES UNDER A HEALTH BENEFIT PLAN.
"DEPARTMENT." THE INSURANCE DEPARTMENT OF THE COMMONWEALTH.
"DRUG MANUFACTURER DIRECT SUPPORT." AN AMOUNT A DRUG MANUFACTURER PAYS IN ANY MANNER TOWARD REDUCING THE COST-SHARING INCURRED BY A COVERED PERSON FOR THE PURCHASE OF A SPECIFIC PRESCRIPTION DRUG.
"GENERICALLY EQUIVALENT DRUG." THE TERM SHALL HAVE THE MEANING GIVEN TO IT IN SECTION 2 OF THE ACT OF NOVEMBER 24, 1976 (P.L.1163, NO.259), KNOWN AS THE GENERIC EQUIVALENT DRUG LAW.
"HEALTH BENEFIT PLAN." THE TERM SHALL HAVE THE MEANING GIVEN TO IT IN THE ACT OF NOVEMBER 21, 2016 (P.L.1318, NO.169), KNOWN 20260HB2226PN3706 - 9 - AS THE PHARMACY BENEFIT REFORM ACT.
"HEALTH CARE PROVIDER." A PERSON WHO IS LICENSED, CERTIFIED OR OTHERWISE REGULATED TO PROVIDE HEALTH CARE SERVICES UNDER THE LAWS OF THIS COMMONWEALTH.
"HEALTH INSURER CLIENT." THE TERM SHALL HAVE THE MEANING GIVEN TO IT IN THE PHARMACY BENEFIT REFORM ACT.
"HEALTH INSURER." THE TERM SHALL HAVE THE MEANING GIVEN TO IT IN THE PHARMACY BENEFIT REFORM ACT.
"INTERCHANGEABLE BIOLOGICAL PRODUCT." THE TERM SHALL HAVE THE MEANING GIVEN TO IT IN SECTION 2 OF THE GENERIC EQUIVALENT DRUG LAW.
"OUT-OF-NETWORK HEALTH CARE PROVIDER." A HEALTH CARE PROVIDER WHO DOES NOT CONTRACT WITH A HEALTH INSURER CLIENT TO PROVIDE HEALTH CARE SERVICES TO A COVERED PERSON UNDER A HEALTH BENEFIT PLAN.
"PHARMACY BENEFITS MANAGER." THE TERM SHALL HAVE THE MEANING GIVEN TO IT IN THE PHARMACY BENEFIT REFORM ACT.
"PRESCRIPTION DRUG." THE TERM SHALL INCLUDE A DRUG, A GENERICALLY EQUIVALENT DRUG, A BIOLOGICAL PRODUCT, AND AN INTERCHANGEABLE BIOLOGICAL PRODUCT, AS THOSE TERMS ARE DEFINED IN SECTION 2 OF THE GENERIC EQUIVALENT DRUG LAW, THAT IS PRESCRIBED BY A HEALTH CARE PROVIDER.
THE TERM SHALL ALSO INCLUDE INSULIN, INSULIN SYRINGES AND INSULIN NEEDLES.
"PRESCRIPTION DRUG COVERAGE ADMINISTRATOR." A HEALTH BENEFIT PLAN, HEALTH INSURER, OR A PHARMACY BENEFITS MANAGER THAT ADMINISTERS PHARMACY BENEFITS FOR A HEALTH INSURER CLIENT.
SUBCHAPTER B FAIR CO-PAY ASSISTANCE CREDITS SEC.
5211.
COST-SHARING CREDIT.
20260HB2226PN3706 - 10 - 5212.
PROHIBITED CREDITING.
5213.
LIMITATIONS.
5214.
EXEMPTED ARRANGEMENTS.
§ 5211.
COST-SHARING CREDIT.
EXCEPT AS PROVIDED IN SECTION 5212 (RELATING TO PROHIBITED CREDITING) OR EXEMPTED BY SECTION 5214 (RELATING TO EXEMPTED ARRANGEMENTS), FOR EACH FILL OF A PRESCRIPTION DRUG, A PRESCRIPTION DRUG COVERAGE ADMINISTRATOR SHALL REDUCE THE COST- SHARING INCURRED BY A COVERED PERSON OR CREDIT TOWARD THE COVERED PERSON'S IN-NETWORK OUT-OF-POCKET MAXIMUM AND OTHER COST-SHARING REQUIREMENTS ANY AMOUNT PAID ON BEHALF OF THE COVERED PERSON BY ANOTHER PERSON FOR THE PRESCRIPTION DRUG, INCLUDING DRUG MANUFACTURER DIRECT SUPPORT, PROVIDED THAT ALL OF THE FOLLOWING APPLY:
(1) THE PRESCRIPTION DRUG IS ON THE COVERED PERSON'S HEALTH INSURANCE POLICY FORMULARY.
(2) THE PRESCRIPTION DRUG EITHER:
(I) DOES NOT HAVE A GENERIC EQUIVALENT DRUG OR INTERCHANGEABLE BIOLOGICAL PRODUCT.
(II) DOES HAVE A GENERIC EQUIVALENT DRUG OR INTERCHANGEABLE BIOLOGICAL PRODUCT BUT THE COVERED PERSON HAS OBTAINED ACCESS TO THE PRESCRIPTION DRUG THROUGH ANY OF THE FOLLOWING:
(A) PRIOR AUTHORIZATION.
(B) A STEP THERAPY PROTOCOL.
(C) THE HEALTH INSURER'S EXCEPTIONS AND APPEALS PROCESS.
§ 5212.
PROHIBITED CREDITING.
A PRESCRIPTION DRUG COVERAGE ADMINISTRATOR MAY NOT CREDIT DRUG MANUFACTURER DIRECT SUPPORT TOWARD THE COVERED PERSON'S IN- 20260HB2226PN3706 - 11 - NETWORK OUT-OF-POCKET MAXIMUM AND OTHER COST-SHARING REQUIREMENTS IF THE SUPPORT IS NOT BOTH:
(1) AVAILABLE TO EACH COVERED PERSON OF EVERY HEALTH INSURANCE POLICY ISSUED OR RENEWED IN THIS COMMONWEALTH.
(2) AVAILABLE IN THE SAME MONETARY AMOUNT FOR EACH INITIAL FILL AND EACH REFILL THROUGHOUT THE PLAN YEAR OF THE COVERED PERSON'S HEALTH INSURANCE POLICY.
§ 5213.
LIMITATIONS.
A PRESCRIPTION DRUG COVERAGE ADMINISTRATOR MAY NOT CREDIT DRUG MANUFACTURER DIRECT SUPPORT TOWARD THE COVERED PERSON'S IN- NETWORK OUT-OF-POCKET MAXIMUM AND OTHER COST-SHARING REQUIREMENTS IF EITHER OF THE FOLLOWING APPLIES:
(1) THE COVERED PERSON'S HEALTH INSURANCE POLICY IS A HIGH DEDUCTIBLE HEALTH PLAN UNDER 26 U.S.C.
§ 223(C) (RELATING TO HEALTH SAVINGS ACCOUNTS) OFFERED IN CONJUNCTION WITH A HEALTH SAVINGS ACCOUNT, THE DRUG MANUFACTURER DIRECT SUPPORT IS USED TOWARDS THE PURCHASE OF A PRESCRIPTION DRUG OTHER THAN AS PERMITTED ON A PRE-DEDUCTIBLE BASIS UNDER 26 U.S.C.
§ 223(C), AND THE DRUG MANUFACTURER DIRECT SUPPORT IS USED DURING ANY PORTION OF THE PLAN YEAR DURING WHICH THE DEDUCTIBLE OF THE HEALTH INSURANCE POLICY IS NOT SATISFIED.
(2) THE CREDIT IS NOT APPLIED TO A HEALTH INSURANCE POLICY WHICH IS IN WHOLE OR IN PART DETERMINED TO BE A FEDERAL HEALTH CARE PROGRAM.
§ 5214.
EXEMPTED ARRANGEMENTS.
(A) AGREEMENT.--A PRESCRIPTION DRUG COVERAGE ADMINISTRATOR SHALL BE EXEMPT FROM THE REQUIREMENTS OF SECTION 5211 (RELATING TO COST-SHARING CREDIT) IF IT ENTERS INTO AN AGREEMENT WITH AN ENTITY THAT PROVIDES DRUG MANUFACTURER DIRECT SUPPORT, PURSUANT TO WHICH THE PRESCRIPTION DRUG COVERAGE ADMINISTRATOR ACCEPTS 20260HB2226PN3706 - 12 - PAYMENTS ON BEHALF OF COVERED PERSONS, PROVIDED THAT THE AGREEMENT COMPLIES WITH ALL PROVISIONS OF THIS CHAPTER.
(B) VOLUNTARY PROGRAM.--A PRESCRIPTION DRUG COVERAGE ADMINISTRATOR'S PROGRAM SHALL BE EXEMPT FROM THE REQUIREMENTS OF THIS CHAPTER IF IT IS A VOLUNTARY PROGRAM OFFERED TO A COVERED PERSON UNDER A HEALTH BENEFIT PLAN IN WHICH THE VALUE OF A PHARMACEUTICAL MANUFACTURER'S ASSISTANCE PROGRAM IS APPLIED TO REDUCE A COVERED PERSON'S OUT-OF-POCKET COSTS TO A FIXED MONTHLY AMOUNT FOR THE BENEFIT YEAR FOR A SPECIFIC PRESCRIPTION AND ANY ACTUAL COST THE COVERED PERSON PAYS WHILE IN THE PROGRAM IS APPLIED TO THE COVERED PERSON'S APPLICABLE OUT-OF-POCKET MAXIMUM RESPONSIBILITY.
SUBCHAPTER C MISCELLANEOUS PROVISIONS SEC.
5221.
PROTECTIONS.
5222.
REGULATIONS.
5223.
ENFORCEMENT.
§ 5221.
PROTECTIONS.
NOTHING IN THIS CHAPTER SHALL REQUIRE A HEALTH BENEFIT PLAN TO CREDIT CO-PAY ASSISTANCE FOR A PRESCRIPTION DRUG IN DEROGATION OF A POLICYHOLDER'S CONSTITUTIONAL PROTECTIONS OF RELIGIOUS FREEDOM UNDER THE ACT OF DECEMBER 9, 2002 (P.L.1701, NO.214), KNOWN AS THE RELIGIOUS FREEDOM PROTECTION ACT, OR 42 U.S.C.
CH.
21B (RELATING TO RELIGIOUS FREEDOM RESTORATION).
§ 5222.
REGULATIONS.
THE DEPARTMENT MAY PROMULGATE REGULATIONS AS NECESSARY AND APPROPRIATE TO CARRY OUT THE PROVISIONS OF THIS CHAPTER.
§ 5223.
ENFORCEMENT.
(A) PENALTIES.--AFTER SATISFACTORY EVIDENCE OF THE VIOLATION 20260HB2226PN3706 - 13 - OF THIS CHAPTER BY A PRESCRIPTION DRUG COVERAGE ADMINISTRATOR, ONE OR MORE OF THE FOLLOWING PENALTIES MAY BE IMPOSED AT THE COMMISSIONER'S DISCRETION:
(1) SUSPENSION OR REVOCATION OF THE OFFENDING ENTITY'S LICENSE OR REGISTRATION.
(2) REFUSAL, FOR A PERIOD NOT TO EXCEED ONE YEAR, TO ISSUE A NEW LICENSE OR REGISTRATION TO THE OFFENDING ENTITY.
(3) A FINE OF NOT MORE THAN $5,000 FOR EACH VIOLATION OF THIS CHAPTER.
(4) A FINE OF NOT MORE THAN $10,000 FOR EACH WILLFUL VIOLATION OF THIS CHAPTER.
(B) LIMITATION.--FINES IMPOSED AGAINST AN ENTITY UNDER THIS SECTION MAY NOT EXCEED $500,000 IN THE AGGREGATE DURING A SINGLE CALENDAR YEAR.
(C) ADDITIONAL REMEDIES.--THE ENFORCEMENT REMEDIES IMPOSED UNDER THIS SECTION ARE IN ADDITION TO ANY OTHER REMEDIES OR PENALTIES THAT MAY BE IMPOSED UNDER ANY OTHER APPLICABLE LAW OF THIS COMMONWEALTH, INCLUDING:
(1) THE ACT OF JULY 22, 1974 (P.L.589, NO.205), KNOWN AS THE UNFAIR INSURANCE PRACTICES ACT.
A VIOLATION OF THIS CHAPTER SHALL BE DEEMED TO BE AN UNFAIR METHOD OF COMPETITION AND AN UNFAIR OR DECEPTIVE ACT OR PRACTICE UNDER THE UNFAIR INSURANCE PRACTICES ACT.
(2) THE ACT OF DECEMBER 18, 1996 (P.L.1066, NO.159), KNOWN AS THE ACCIDENT AND HEALTH FILING REFORM ACT.
(3) THE ACT OF JUNE 25, 1997 (P.L.295, NO.29), KNOWN AS THE PENNSYLVANIA HEALTH CARE INSURANCE PORTABILITY ACT.
(4) THE ACT OF NOVEMBER 21, 2016 (P.L.1318, NO.169), AS AMENDED, KNOWN AS THE PHARMACY BENEFIT REFORM ACT.
(D) ADMINISTRATIVE PROCEDURE.--THE ADMINISTRATIVE PROVISIONS 20260HB2226PN3706 - 14 - OF THIS CHAPTER SHALL BE SUBJECT TO 2 PA.C.S.
CH.
5 SUBCH.
A (RELATING TO PRACTICE AND PROCEDURE OF COMMONWEALTH AGENCIES).
A PARTY AGAINST WHOM PENALTIES ARE ASSESSED IN AN ADMINISTRATIVE ACTION MAY APPEAL TO COMMONWEALTH COURT AS PROVIDED IN 2 PA.C.S.
CH.
7 SUBCH.
A (RELATING TO JUDICIAL REVIEW OF COMMONWEALTH AGENCY ACTION).
SECTION 2.
THE FOLLOWING SHALL APPLY:
(1) FOR HEALTH BENEFIT PLANS FOR WHICH EITHER RATES OR FORMS ARE REQUIRED TO BE FILED WITH THE DEPARTMENT, THIS CHAPTER SHALL APPLY TO ANY POLICY FOR WHICH A FORM OR RATE IS FIRST FILED ON OR AFTER THE EFFECTIVE DATE OF THIS SUBPARAGRAPH.
(2) FOR HEALTH BENEFIT PLANS FOR WHICH NEITHER RATES NOR FORMS ARE REQUIRED TO BE FILED WITH THE DEPARTMENT, THIS CHAPTER SHALL APPLY TO ANY POLICY ISSUED OR RENEWED ON OR AFTER 180 DAYS AFTER THE EFFECTIVE DATE OF THIS SUBPARAGRAPH.
SECTION 3.
THIS ACT SHALL TAKE EFFECT AS FOLLOWS:
(1) SECTION 2 OF THIS ACT AND THIS SECTION SHALL TAKE EFFECT IMMEDIATELY.
(2) THE REMAINDER OF THIS ACT SHALL TAKE EFFECT IN 60 DAYS.
20260HB2226PN3706 - 15 -
View plain text versions (2)

Action History

  1. Re-committed to Rules

  2. First consideration

  3. Reported as amended

  4. Referred to Insurance

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 31 co-sponsors · 221 not signed on · 12 voted No

Sponsors (1)

Co-sponsors (31)

Not signed on (221)

221 members have not signed on to this bill.

Show all 221 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Passed 14 Yea · 12 Nay
Party YeaNayPresentNot Voting
Democratic 14000
Republican 01200
Total 141200
% of votes cast 54%46%0%0%
How each member voted (26)
Member Party Vote
Aerion Abney Democratic Yea
Arvind Venkat Democratic Yea
Brian Munroe Democratic Yea
Bridget M. Kosierowski Democratic Yea
Christina D. Sappey Democratic Yea
Darisha K. Parker Democratic Yea
Greg Scott Democratic Yea
Jim Haddock Democratic Yea
Kyle J. Mullins Democratic Yea
Morgan Cephas Democratic Yea
Perry S. Warren Democratic Yea
Robert E. Merski Democratic Yea
Steven R. Malagari Democratic Yea
Tim Brennan Democratic Yea
Aaron Bernstine Republican Nay
Ann Flood Republican Nay
Dane Watro Republican Nay
David H. Zimmerman Republican Nay
Eric R. Nelson Republican Nay
Jeff Olsommer Republican Nay
Jonathan Fritz Republican Nay
Keith J. Greiner Republican Nay
Robert Leadbeter Republican Nay
Steven C. Mentzer Republican Nay
Thomas H. Kutz Republican Nay
Tina Pickett Republican Nay

Official roll call →

Passed 14 Yea · 12 Nay
Party YeaNayPresentNot Voting
Democratic 14000
Republican 01200
Total 141200
% of votes cast 54%46%0%0%
How each member voted (26)
Member Party Vote
Aerion Abney Democratic Yea
Arvind Venkat Democratic Yea
Brian Munroe Democratic Yea
Bridget M. Kosierowski Democratic Yea
Christina D. Sappey Democratic Yea
Darisha K. Parker Democratic Yea
Greg Scott Democratic Yea
Jim Haddock Democratic Yea
Kyle J. Mullins Democratic Yea
Morgan Cephas Democratic Yea
Perry S. Warren Democratic Yea
Robert E. Merski Democratic Yea
Steven R. Malagari Democratic Yea
Tim Brennan Democratic Yea
Aaron Bernstine Republican Nay
Ann Flood Republican Nay
Dane Watro Republican Nay
David H. Zimmerman Republican Nay
Eric R. Nelson Republican Nay
Jeff Olsommer Republican Nay
Jonathan Fritz Republican Nay
Keith J. Greiner Republican Nay
Robert Leadbeter Republican Nay
Steven C. Mentzer Republican Nay
Thomas H. Kutz Republican Nay
Tina Pickett Republican Nay

Official roll call →

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HB 2226?
HB 2226 is sponsored by Emily Kinkead (Democratic), Andrew Kuzma (Republican), Tarik Khan (Democratic), Liz Hanbidge (Democratic), Darisha K. Parker (Democratic), Jeanne McNeill (Democratic), Ben Waxman (Democratic), Carol Hill-Evans (Democratic), Johanny Cepeda-Freytiz (Democratic), Manuel Guzman (Democratic), Melissa Cerrato (Democratic), Joseph C. Hohenstein (Democratic), Greg Scott (Democratic), Sean Dougherty (Democratic), Justin C. Fleming (Democratic), Valerie S. Gaydos (Republican), Melissa L. Shusterman (Democratic), Jim Prokopiak (Democratic), Kristine C. Howard (Democratic), Benjamin V. Sanchez (Democratic), Carol Kazeem (Democratic), Abigail Salisbury (Democratic), Milou Mackenzie (Republican), Elizabeth Fiedler (Democratic), Chris Pielli (Democratic), Tim Brennan (Democratic), Maureen E. Madden (Democratic), Robert F. Matzie (Democratic), Brandon J. Markosek (Democratic), Dan Goughnour (Democratic), Tim Briggs (Democratic), and Paul Friel (Democratic).
What is the current status of HB 2226?
This bill is in committee in the House. Introduced February 19, 2026. It must pass committee before a floor vote.
Where can I track HB 2226?
Track HB 2226 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 2226

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of HB 2226

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →